Application of CRISPR/Cas9 in Alzheimer’s Disease

Overview of attention for article published in Frontiers in Neuroscience, December 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news: 3 news outlets

twitter: 4 X users

Citations

dimensions_citation: 22 Dimensions

Readers on

mendeley: 82 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 3 news stories from 3 outlets.

Recherche préclinique sur l’édition de gènes basée sur CRISPR pour le traitement de la maladie d’Alzheimer : Brent D. Aulston, PhD

Nouvelles du monde, 16 Jul 2023

TEMPS DE REGARDE : 5 minutes “Nous ciblons une séquence qui est pertinente à la fois pour la MA familiale et également…

Preclinical Research on CRISPR-Based Gene Editing for Alzheimer Disease Treatment: Brent D. Aulston, PhD

Neurology Live, 16 Jul 2023

WATCH TIME: 5 minutes "We target a sequence that is relevant for both familial AD, and also applicable to sporadic AD.

Application of CRISPR/Cas9 in Alzheimer's Disease.

Alzforum, 14 Jan 2022

Lu L, Yu X, Cai Y, Sun M, Yang H. Front Neurosci. 2021;15:803894. Epub 2021 Dec 21 PubMed.

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.